Tag: Suicidal Thoughts

By Posted on Posted in Adverse Drug Reaction [ADR], Genetic Predisposition, Genetic Susceptibility, New Safety Information, Personalized Medicine, Regulatory Announcement, Thasso Post, Theragenomic Medicine, Theragenomics, Theragenomics of Individualized Drug Safety Tagged with , , , , , , , , , , , , ,

August 04, 2023 – We at thasso recently had an article (blog) on the much discussed and recently throughout the social media as wonder compound (drug) for weight loss promoted active ingredient Semaglutide in the form of the newly marketed product …

Is there living pharmacogenovigilance behind Semaglutide drugs? Read more »

By Posted on Posted in New Drug Approval, Thasso Post Tagged with , , , , , , , , , , , ,

December 23, 2014 – The U.S. Food and Drug Administration (FDA) just approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use …

The weight-management drug Liraglutide (Saxenda) has just been approved by the FDA Read more »